Ausgabe 3/2016
Inhalt (8 Artikel)
Altered primary chromatin structures and their implications in cancer development
Angelo Ferraro
Simultaneous detection of circulating immunological parameters and tumor biomarkers in early stage breast cancer patients during adjuvant chemotherapy
B. Rovati, S. Mariucci, S. Delfanti, D. Grasso, C. Tinelli, C. Torre, M. De Amici, P. Pedrazzoli
Small-molecule inhibitors of FGFR, integrins and FAK selectively decrease L1CAM-stimulated glioblastoma cell motility and proliferation
Hannah J. Anderson, Deni S. Galileo
Biomarkers for the identification of precursor polyps of colorectal serrated adenocarcinomas
José García-Solano, María Eulalia García-Solano, Daniel Torres-Moreno, Pablo Carbonell, Javier Trujillo-Santos, Miguel Pérez-Guillermo, Pablo Conesa-Zamora
Cytotoxicity of allitinib, an irreversible anti-EGFR agent, in a large panel of human cancer-derived cell lines: KRAS mutation status as a predictive biomarker
Renato José Silva-Oliveira, Viviane Aline Oliveira Silva, Olga Martinho, Adriana Cruvinel-Carloni, Matias Eliseo Melendez, Marcela Nunes Rosa, Flávia Escremim de Paula, Luciano de Souza Viana, André Lopes Carvalho, Rui Manuel Reis
A novel curcumin-like dienone induces apoptosis in triple-negative breast cancer cells
Elisa Robles-Escajeda, Umashankar Das, Nora M. Ortega, Karla Parra, Giulio Francia, Jonathan R. Dimmock, Armando Varela-Ramirez, Renato J. Aguilera
Tumor-specific promoter-driven adenoviral therapy for insulinoma
Alan Wei-Shun Tseng, Chiachen Chen, Mary B. Breslin, Michael S. Lan
Inactivation of CYLD in intestinal epithelial cells exacerbates colitis-associated colorectal carcinogenesis - a short report
Demetrios N. Karatzas, Konstantinos Xanthopoulos, Panorea Kotantaki, Athanasios Pseftogas, Konstantinos Teliousis, Eudoxia G. Hatzivassiliou, Dimitris L Kontoyiannis, Theofilos Poutahidis, George Mosialos